On the 14th of July CFDA issued a statement clarifying that all infant formula and FSMP product itaking ferrous fumaratemported prior to Jan 1st 2018 can be sold until its expiration in China. To clarify the situation CFDA has also stipulatferrous fumarate que esed that all product must have undergone full complianiron ferric pyrophosphate folic acid and glycinecferro f tab side effectse inspection and ferrous lactate dairy allergyapproval before the January 1st deadline to be eligible for this infant formula and FSMP registration transitional measure.
China Clarifies Infant Formula and FSMP Registration and Import Deadline Stipulations
